CN
CN
CN

Shanghai Minhang R&D Center

Here is Porton's largest R&D center, designed to provide customers with DS to DP R&D services.
No. 188, Beidou Road, Minhang District, Shanghai, China

    19+Years

    The R&D center team was established in 2007 and has a wealth of project experience.

    2Buildings

    Major departments include the Small Molecules Process Development Department, the Analytical Development Department, the Kilogram Laboratory, and the Safety Laboratory

    22,000m2Area

    Porton Science & Technology Center and Macromolecule Synthesis R&D Center are also located here.

Services

Small Molecules TIDES
Small Molecules
Porton offers efficient, flexible, and high-quality solutions for custom development and production of small molecule APIs, as well as technical services throughout the entire lifecycle from preclinical to commercial stages to our worldwide partners.

More

Small Molecules
TIDES
With five major R&D platforms, including peptides, oligonucleotides, conjugate products, high-performance liquid chromatography, and Tides analysis, the Porton Tides CDMO Services Platform is committed to providing integrated CMC solutions for global customers, covering all types of new drugs from preclinical to commercial.

More

TIDES

Technology Platform

Porton's new technology platform focuses on providing advanced and green chemical technology solutions, dedicated to accelerating drug research, development, and production processes. Our platform encompasses a wide range of capabilities, including Crystallization, Biocatalysis, Flow Chemistry, High-Throughput, and Photochemistry.
High Potency R&D Facilities

High Potency R&D Facilities

Our 500 ㎡ high-potency laboratory is designed to meet OEB 5 (OEL < 0.05 µg/m³) standards. Our facility boasts 8 isolators, 3 advanced purification units, and 4 lyophilizers. This exceptional setup ensures optimal conditions for the research and development of HPAPI.

One Porton One Quality

Compliance Standards, Continuous Improvement, and Customer Oriented
Quality management runs throughout the entire process of the drug life cycle. The quality management system of the R&D center is built in accordance with international standards and continues to adhere to the quality concept of 'more well-established system, more controllable quality.' This ensures that the GMP activities of the R&D center meet the requirements of international quality management systems and market drug regulatory agencies, including those of China, the European Union, FDA, and other mainstream regulations.
Become part of Porton's community to access personalized insights and resources.
Subscribe to the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

This website contains product information intended for different regions and may include details that are not available or authorized in your country. Please be aware that we assume no responsibility for any access to such information that may contravene applicable laws, regulations, or usage restrictions in your jurisdiction.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.
US: (609) 860-1300
CN: (86) 23-8608-3200